Clinical analysis of effect and cardio-toxicity of gefitinib and docetaxel in treatment of elderly patients with advanced lung adenocarcinoma

CLINICAL FOCUS ›› 2011, Vol. 26 ›› Issue (13): 1131-1133.

Previous Articles Next Articles

Clinical analysis of effect and cardio-toxicity of gefitinib and docetaxel in treatment of elderly patients with advanced lung adenocarcinoma

CUI Rong;WU Yong-juan;YANG Yan-xia;HUA Yun-qi;LIU Li-ping;TAN Ya-qin;ZHANG Wen-hui;YUAN Hai-qing

Online:2011-07-05 Published:2011-07-05

Abstract

CLC Number:

R730.51

CUI Rong;WU Yong-juan;YANG Yan-xia;HUA Yun-qi;LIU Li-ping;TAN Ya-qin;ZHANG Wen-hui;YUAN Hai-qing . Clinical analysis of effect and cardio-toxicity of gefitinib and docetaxel in treatment of elderly patients with advanced lung adenocarcinoma[J]. CLINICAL FOCUS, 2011, 26(13): 1131-1133.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2011/V26/I13/1131

[1]	. [J]. Clinical Focus, 2012, 27(11): 1005-1008.
[2]	. Combination of ibandronate monosodium and chemotherapy in treating patients with malignant tumor bone metastases [J]. CLINICAL FOCUS, 2004, 19(16): 933-934.

Clinical analysis of effect and cardio-toxicity of gefitinib and docetaxel in treatment of elderly patients with advanced lung adenocarcinoma

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 2

Recommended Articles

Metrics

Comments